Rallybio RLYB
NASDAQ RLYB
$16.92 -0.30 (-1.71%)
As of: Sep 30, 2026 · 9:37 AM EDT

Rallybio (RLYB) Operating Leases (2022 - 2026)

Updated

Rallybio (RLYB) recorded Operating Leases of $55,000 in Q1 2026, down 32.9% from the prior quarter.

Analysis

Rallybio (RLYB) Operating Leases (2022 - 2026) Analysis & Trends

At the end of FY2025, Rallybio reported Operating Leases of $82,000.

  • Annual Operating Leases has a three-year compound annual growth rate of -39.7% (FY2022 to FY2025).
  • Across earlier years, Operating Leases came in at $173,000 in FY2023 (-53.7%) and $374,000 in FY2022.
  • The Q1 2026 figure is the lowest quarterly Operating Leases in data going back to Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Rallybio 90.48 Mn 90.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 55,000.00
Dec 31, 2025 82,000.00
Sep 30, 2025 108,000.00
Jun 30, 2024 58,000.00
Mar 31, 2024 116,000.00
Dec 31, 2023 173,000.00
Sep 30, 2023 211,000.00
Jun 30, 2023 266,000.00
Mar 31, 2023 321,000.00
Dec 31, 2022 374,000.00
Sep 30, 2022 428,000.00
Jun 30, 2022 478,000.00
Mar 31, 2022 517,000.00
API Access

Rallybio Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=RLYB&period=max&api_key=YOUR_API_KEY